Combination of clofarabine, cyclophosphamide, and etoposide for relapsed or refractory childhood and adolescent acute myeloid leukemia.

about

Combination of clofarabine, cyclophosphamide, and etoposide for relapsed or refractory childhood and adolescent acute myeloid leukemia.

Item

http://www.wikidata.org/entity/Q48175362

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Combination of clofarabine, cy ...... escent acute myeloid leukemia.

@en

Combination of clofarabine, cy ...... escent acute myeloid leukemia.

@nl

type

Item

label

Combination of clofarabine, cy ...... escent acute myeloid leukemia.

@en

Combination of clofarabine, cy ...... escent acute myeloid leukemia.

@nl

prefLabel

Combination of clofarabine, cy ...... escent acute myeloid leukemia.

@en

Combination of clofarabine, cy ...... escent acute myeloid leukemia.

@nl

P1476

Combination of clofarabine, cy ...... escent acute myeloid leukemia.

@en

P2093

Alissa Martin

http://www.w3.org/2001/XMLSchema#string

Javier Oesterheld

http://www.w3.org/2001/XMLSchema#string

Jessica Boklan

http://www.w3.org/2001/XMLSchema#string

Joanna Weinstein

http://www.w3.org/2001/XMLSchema#string

John Goldberg

http://www.w3.org/2001/XMLSchema#string

Nobuko Hijiya

http://www.w3.org/2001/XMLSchema#string

Oussama Abla

http://www.w3.org/2001/XMLSchema#string

Steven G DuBois

http://www.w3.org/2001/XMLSchema#string

P2860

Clofarabine plus cytarabine compared with cytarabine alone in older patients with relapsed or refractory acute myelogenous leukemia: results from the CLASSIC I Trial

Clofarabine, idarubicin, and cytarabine (CIA) as frontline therapy for patients ≤60 years with newly diagnosed acute myeloid leukemia.

Effectiveness of supportive care measures to reduce infections in pediatric AML: a report from the Children's Oncology Group

Phase 2 trial of clofarabine in combination with etoposide and cyclophosphamide in pediatric patients with refractory or relapsed acute lymphoblastic leukemia.

A comparison of clofarabine with ara-C, each in combination with daunorubicin as induction treatment in older patients with acute myeloid leukaemia.

Clofarabine for the treatment of adult acute lymphoid leukemia: the Group for Research on Adult Acute Lymphoblastic Leukemia intergroup.

Therapeutic value of clofarabine in younger and middle-aged (18-65 years) adults with newly diagnosed AML.

Revised recommendations of the International Working Group for Diagnosis, Standardization of Response Criteria, Treatment Outcomes, and Reporting Standards for Therapeutic Trials in Acute Myeloid Leukemia.

A Phase I Study of Clofarabine With Multiagent Chemotherapy in Childhood High Risk Relapse of Acute Lymphoblastic Leukemia (VANDEVOL Study of the French SFCE Acute Leukemia Committee).

Low-dose clofarabine in combination with a standard remission induction in patients aged 18-60 years with previously untreated intermediate and bad-risk acute myeloid leukemia or high-risk myelodysplastic syndrome: combined phase I/II results of the

P304

187-198

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1080/08880018.2017.1360970

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Yoav Messinger

P577

2017-10-17T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29039989

http://www.w3.org/2001/XMLSchema#string

P921

teenager